Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-17
2007-07-17
Kwon, Brian (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S356000, C514S474000, C514S562000, C514S564000, C514S725000, C514S423000, C514S458000
Reexamination Certificate
active
10765236
ABSTRACT:
The present invention provides compositions and methods for lowering plasma Lp(a) levels in humans. The present invention provides compositions and methods for lowering the risk factors for cardiovascular diseases. Moreover, this invention provides therapeutic alternatives to current pharmaceutical interventions for the lowering of cholesterol, LDL-cholesterol, triglycerides and other metabolic risk factors.
REFERENCES:
patent: 4009265 (1977-02-01), Howard
patent: 4414238 (1983-11-01), Schmidl
patent: 4657866 (1987-04-01), Kumar
patent: 4891220 (1990-01-01), Donzis
patent: 5108767 (1992-04-01), Mulchandani et al.
patent: 5230996 (1993-07-01), Rath et al.
patent: 5268181 (1993-12-01), Neill et al.
patent: 5278189 (1994-01-01), Rath et al.
patent: 5326569 (1994-07-01), Acosta et al.
patent: 5332579 (1994-07-01), Umbdenstock
patent: 5650418 (1997-07-01), Rath et al.
patent: 5922766 (1999-07-01), Acosta et al.
patent: 5962517 (1999-10-01), Murad
patent: 6048846 (2000-04-01), Cochran
patent: 6245803 (2001-06-01), Acosta et al.
patent: 6299896 (2001-10-01), Cooper et al.
patent: 6361800 (2002-03-01), Cooper et al.
patent: 6451341 (2002-09-01), Slaga et al.
patent: 2002/0128309 (2002-09-01), Rath
patent: 2002/0173546 (2002-11-01), Rath
patent: 2003/0003162 (2003-01-01), Rath
patent: 0891771 (1999-01-01), None
patent: 1068868 (2001-01-01), None
patent: 1163904 (2001-12-01), None
patent: 1195159 (2002-10-01), None
patent: 2268871 (1994-01-01), None
Kennedy, R.Lipoprotein(a),Vascular Disease, and Vitamin C. The Doctor's Medial Library, www.medical-library.net, Jan. 5, 1999.
Dardik et al.,A Quantitative Assay for the Non-Covalent Association Between Apolipoprotein(a)and Apolipoprotein B: An Alternative Measure of Lp(a)Assembly. Journal of Lipid Research, vol. 41, 2000, esp. p. 1018, para 4.
Life Extension Mix Multivitamin, Product Information Brochure, www.iherb.com. 1997.
Multi Li Caps, Product Information Brochure, www.solgar.com, 1996.
Mega Vita-Min, Product Information Brochure, www.naturesbounty.com, 2000.
Vinson, Joe A, et al.,A Citrus Extract Plus Ascorbic Acid Decreases Lipids, Lipid Peroxides, Lipoprotein Oxidative Susceptibility, and Atherosclerosis in Hypercholesterolemic Hamsters, J. Agric. Food Chem, vol. 46, pp. 1453-1459, 1998.
Giroux, Isabelle et al.,Role of dietary lysine, methionine, and arginine in the regulation of hypercholesterolemia in rabbits, J. Nutr. Biochem., vol. 10, pp. 166-171, 1991.
Troger U. and Meyer F.P., British Medical Journal (1998) vol. 317, pp. 1069-1071.
Kostner, “HMG CoA reductase inhibitor lower LDL cholesterol without reducing Lp(a) levels” Circulation, Nov. 1989, vol. 80 No. 5, pp. 1313-1319.
Hegele, “The effect of genetic determinants of low density lipoprotein levels on lipoprotein (a)” Clin Invest Med, Apr. 1991, vol. 14 No. 2, pp. 146-152.
Watts, “Liprotein (a) as an Independent . . . common hypercholesterolaemia” J Clin Pathol, Mar. 1993, vol. 46 No. 3, pp. 267-270.
Olofinskaia, “Lipoprotein (A) in patients with coronary atherosclerosis” Kardiologiia, Oct. 1991, vol. 31 No. 10, pp. 36-38.
Chen, Esq. Alexander
Inhouse Co
Kamarei, Esq. Ali
Kwon Brian
LandOfFree
Compositions and methods for lowering plasma lipoprotein(a)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for lowering plasma lipoprotein(a)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for lowering plasma lipoprotein(a)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767438